APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Exosome CDMO

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Exosome CDMO Industry Growth and Trends Forecast to 2032

Report ID 17413724011 January 2026114 pages

Choose your research edition.

Industry ResearchExosome CDMO Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Exosome CDMO Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Exosome CDMO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Exosome CDMO Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Exosome CDMO Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

According to APO Research, the global Exosome CDMO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Exosome CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Exosome CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Exosome CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Exosome CDMO market include REPROCELL, Histocell, Lonza, MYCENAX, RoosterBio, Altaris LLC, Asahi Glass Co., Fortis Life Sciences and Scorpius BioManufacturing, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Exosome CDMO market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Exosome CDMO market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Exosome CDMO market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Exosome CDMO.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Exosome CDMO market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Exosome CDMO Market by Company

REPROCELL

Histocell

Lonza

MYCENAX

RoosterBio

Altaris LLC

Asahi Glass Co.

Fortis Life Sciences

Scorpius BioManufacturing

Miltenyi Bioindustry

Exothera

EXO Biologics

Porton Advanced

Elise Biopharma

Evox Therapeutics

FUJIFILM Biotechnologies

Exosome CDMO Segment by Type

Preclinical CRO

Clinical CRO

Exosome CDMO Segment by Application

Laboratory

Universities

Bio Industry

Medical Industry

Exosome CDMO Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exosome CDMO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Exosome CDMO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exosome CDMO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Exosome CDMO companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Exosome CDMO Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Exosome CDMO Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Exosome CDMO Market Share by Region (2021-2026) Table 4. Global Exosome CDMO Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Exosome CDMO Market Share by Region (2027-2032) Table 6. Global Exosome CDMO Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Exosome CDMO Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Exosome CDMO Market Size Share by Type (2021-2026) Table 9. Global Exosome CDMO Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Exosome CDMO Market Size Share Forecasted by Type (2027-2032) Table 11. North America Exosome CDMO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Exosome CDMO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Exosome CDMO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Exosome CDMO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Exosome CDMO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Exosome CDMO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Exosome CDMO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Exosome CDMO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Exosome CDMO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Exosome CDMO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Exosome CDMO Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Exosome CDMO Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Exosome CDMO Market Size Share by Application (2021-2026) Table 24. Global Exosome CDMO Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Exosome CDMO Market Size Share Forecasted by Application (2027-2032) Table 26. North America Exosome CDMO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Exosome CDMO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Exosome CDMO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Exosome CDMO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Exosome CDMO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Exosome CDMO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Exosome CDMO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Exosome CDMO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Exosome CDMO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Exosome CDMO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Exosome CDMO Industry Trends Table 37. Exosome CDMO Industry Drivers Table 38. Exosome CDMO Industry Opportunities and Challenges Table 39. Exosome CDMO Industry Restraints Table 40. Global Exosome CDMO Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Exosome CDMO Revenue Market Share by Company (2021-2026) Table 42. Global Exosome CDMO Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Exosome CDMO Key Company Headquarters & Area Served Table 44. Global Exosome CDMO Company, Product Type & Application Table 45. Global Exosome CDMO Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Exosome CDMO by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. REPROCELL Company Information Table 49. REPROCELL Business Overview Table 50. REPROCELL Exosome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. REPROCELL Exosome CDMO Product Portfolio Table 52. REPROCELL Recent Development Table 53. Histocell Company Information Table 54. Histocell Business Overview Table 55. Histocell Exosome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Histocell Exosome CDMO Product Portfolio Table 57. Histocell Recent Development Table 58. Lonza Company Information Table 59. Lonza Business Overview Table 60. Lonza Exosome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Lonza Exosome CDMO Product Portfolio Table 62. Lonza Recent Development Table 63. MYCENAX Company Information Table 64. MYCENAX Business Overview Table 65. MYCENAX Exosome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. MYCENAX Exosome CDMO Product Portfolio Table 67. MYCENAX Recent Development Table 68. RoosterBio Company Information Table 69. RoosterBio Business Overview Table 70. RoosterBio Exosome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. RoosterBio Exosome CDMO Product Portfolio Table 72. RoosterBio Recent Development Table 73. Altaris LLC Company Information Table 74. Altaris LLC Business Overview Table 75. Altaris LLC Exosome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Altaris LLC Exosome CDMO Product Portfolio Table 77. Altaris LLC Recent Development Table 78. Asahi Glass Co. Company Information Table 79. Asahi Glass Co. Business Overview Table 80. Asahi Glass Co. Exosome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Asahi Glass Co. Exosome CDMO Product Portfolio Table 82. Asahi Glass Co. Recent Development Table 83. Fortis Life Sciences Company Information Table 84. Fortis Life Sciences Business Overview Table 85. Fortis Life Sciences Exosome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Fortis Life Sciences Exosome CDMO Product Portfolio Table 87. Fortis Life Sciences Recent Development Table 88. Scorpius BioManufacturing Company Information Table 89. Scorpius BioManufacturing Business Overview Table 90. Scorpius BioManufacturing Exosome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Scorpius BioManufacturing Exosome CDMO Product Portfolio Table 92. Scorpius BioManufacturing Recent Development Table 93. Miltenyi Bioindustry Company Information Table 94. Miltenyi Bioindustry Business Overview Table 95. Miltenyi Bioindustry Exosome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Miltenyi Bioindustry Exosome CDMO Product Portfolio Table 97. Miltenyi Bioindustry Recent Development Table 98. Exothera Company Information Table 99. Exothera Business Overview Table 100. Exothera Exosome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Exothera Exosome CDMO Product Portfolio Table 102. Exothera Recent Development Table 103. EXO Biologics Company Information Table 104. EXO Biologics Business Overview Table 105. EXO Biologics Exosome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. EXO Biologics Exosome CDMO Product Portfolio Table 107. EXO Biologics Recent Development Table 108. Porton Advanced Company Information Table 109. Porton Advanced Business Overview Table 110. Porton Advanced Exosome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Porton Advanced Exosome CDMO Product Portfolio Table 112. Porton Advanced Recent Development Table 113. Elise Biopharma Company Information Table 114. Elise Biopharma Business Overview Table 115. Elise Biopharma Exosome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Elise Biopharma Exosome CDMO Product Portfolio Table 117. Elise Biopharma Recent Development Table 118. Evox Therapeutics Company Information Table 119. Evox Therapeutics Business Overview Table 120. Evox Therapeutics Exosome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Evox Therapeutics Exosome CDMO Product Portfolio Table 122. Evox Therapeutics Recent Development Table 123. FUJIFILM Biotechnologies Company Information Table 124. FUJIFILM Biotechnologies Business Overview Table 125. FUJIFILM Biotechnologies Exosome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. FUJIFILM Biotechnologies Exosome CDMO Product Portfolio Table 127. FUJIFILM Biotechnologies Recent Development Table 128. North America Exosome CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Exosome CDMO Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Exosome CDMO Market Share by Country (2021-2026) Table 131. North America Exosome CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Exosome CDMO Market Share Forecast by Country (2027-2032) Table 133. Europe Exosome CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Exosome CDMO Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Exosome CDMO Market Share by Country (2021-2026) Table 136. Europe Exosome CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Exosome CDMO Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Exosome CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Exosome CDMO Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Exosome CDMO Market Share by Country (2021-2026) Table 141. Asia-Pacific Exosome CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Exosome CDMO Market Share Forecast by Country (2027-2032) Table 143. Latin America Exosome CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Exosome CDMO Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Exosome CDMO Market Share by Country (2021-2026) Table 146. Latin America Exosome CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Exosome CDMO Market Share Forecast by Country (2027-2032) Table 148. Middle East & Africa Exosome CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East & Africa Exosome CDMO Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East & Africa Exosome CDMO Market Share by Country (2021-2026) Table 151. Middle East & Africa Exosome CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East & Africa Exosome CDMO Market Share Forecast by Country (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Exosome CDMO Product Image Figure 3. Global Exosome CDMO Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Exosome CDMO Market Size (2021-2032) & (US$ Million) Figure 5. Global Exosome CDMO Market Share by Region: 2025 VS 2032 Figure 6. Global Exosome CDMO Market Share by Region (2021-2032) Figure 7. North America Exosome CDMO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Exosome CDMO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Exosome CDMO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Exosome CDMO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Exosome CDMO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Preclinical CRO Image Figure 13. Global Preclinical CRO Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Clinical CRO Image Figure 15. Global Clinical CRO Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Exosome CDMO Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Exosome CDMO Market Share by Type 2025 VS 2032 Figure 18. North America Exosome CDMO Market Size Share by Type (2021-2032) Figure 19. Europe Exosome CDMO Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Exosome CDMO Market Size Share by Type (2021-2032) Figure 21. Latin America Exosome CDMO Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Exosome CDMO Market Size Share by Type (2021-2032) Figure 23. Laboratory Image Figure 24. Global Laboratory Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Universities Image Figure 26. Global Universities Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Bio Industry Image Figure 28. Global Bio Industry Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Medical Industry Image Figure 30. Global Medical Industry Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Exosome CDMO Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Exosome CDMO Market Share by Application 2025 VS 2032 Figure 33. North America Exosome CDMO Market Size Share by Application (2021-2032) Figure 34. Europe Exosome CDMO Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Exosome CDMO Market Size Share by Application (2021-2032) Figure 36. Latin America Exosome CDMO Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Exosome CDMO Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Exosome CDMO Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Exosome CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Exosome CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Exosome CDMO Market Share by Country (2021-2032) Figure 43. Europe Exosome CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Exosome CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Exosome CDMO Market Share by Country (2021-2032) Figure 46. Asia-Pacific Exosome CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Exosome CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Exosome CDMO Market Share by Country (2021-2032) Figure 49. Latin America Exosome CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Exosome CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Exosome CDMO Market Share by Country (2021-2032) Figure 52. Middle East & Africa Exosome CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Exosome CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Exosome CDMO Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Preclinical CRO
  • Clinical CRO
Applications
  • Laboratory
  • Universities
  • Bio Industry
  • Medical Industry
Companies covered
  • REPROCELL
  • Histocell
  • Lonza
  • MYCENAX
  • RoosterBio
  • Altaris LLC
  • Asahi Glass Co.
  • Fortis Life Sciences
  • Scorpius BioManufacturing
  • Miltenyi Bioindustry
  • Exothera
  • EXO Biologics
  • Porton Advanced
  • Elise Biopharma
  • Evox Therapeutics
  • FUJIFILM Biotechnologies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Exosome CDMO Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Exosome CDMO Market Size by Region (2021-2032)
  5. 1.4.1 Global Exosome CDMO Market Size by Region (2021-2026)
  6. 1.4.2 Global Exosome CDMO Market Size by Region (2027-2032)
  7. 1.5 Key Regions Exosome CDMO Market Size (2021-2032)
  8. 1.5.1 North America Exosome CDMO Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Exosome CDMO Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Exosome CDMO Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Exosome CDMO Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Exosome CDMO Market Size Growth Rate (2021-2032)
2 Exosome CDMO Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Preclinical CRO
  3. 2.1.2 Clinical CRO
  4. 2.2 Global Exosome CDMO Market Size by Type
  5. 2.2.1 Global Exosome CDMO Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Exosome CDMO Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Exosome CDMO Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Exosome CDMO Market Size by Regions
  9. 2.3.1 North America Exosome CDMO Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Exosome CDMO Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Exosome CDMO Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Exosome CDMO Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Exosome CDMO Market Size Breakdown by Type (2021-2026)
3 Exosome CDMO Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Laboratory
  3. 3.1.2 Universities
  4. 3.1.3 Bio Industry
  5. 3.1.4 Medical Industry
  6. 3.2 Global Exosome CDMO Market Size by Application
  7. 3.2.1 Global Exosome CDMO Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Exosome CDMO Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Exosome CDMO Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Exosome CDMO Market Size by Regions
  11. 3.3.1 North America Exosome CDMO Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Exosome CDMO Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Exosome CDMO Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Exosome CDMO Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Exosome CDMO Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Exosome CDMO Industry Trends
  2. 4.2 Exosome CDMO Industry Drivers
  3. 4.3 Exosome CDMO Industry Opportunities and Challenges
  4. 4.4 Exosome CDMO Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Exosome CDMO Revenue (2021-2026)
  2. 5.2 Global Exosome CDMO Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Exosome CDMO Key Company Headquarters & Area Served
  4. 5.4 Global Exosome CDMO Company, Product Type & Application
  5. 5.5 Global Exosome CDMO Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Exosome CDMO Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Exosome CDMO Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Exosome CDMO Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 REPROCELL
  2. 6.1.1 REPROCELL Company Information
  3. 6.1.2 REPROCELL Business Overview
  4. 6.1.3 REPROCELL Exosome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 REPROCELL Exosome CDMO Product Portfolio
  6. 6.1.5 REPROCELL Recent Developments
  7. 6.2 Histocell
  8. 6.2.1 Histocell Company Information
  9. 6.2.2 Histocell Business Overview
  10. 6.2.3 Histocell Exosome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Histocell Exosome CDMO Product Portfolio
  12. 6.2.5 Histocell Recent Developments
  13. 6.3 Lonza
  14. 6.3.1 Lonza Company Information
  15. 6.3.2 Lonza Business Overview
  16. 6.3.3 Lonza Exosome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Lonza Exosome CDMO Product Portfolio
  18. 6.3.5 Lonza Recent Developments
  19. 6.4 MYCENAX
  20. 6.4.1 MYCENAX Company Information
  21. 6.4.2 MYCENAX Business Overview
  22. 6.4.3 MYCENAX Exosome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 MYCENAX Exosome CDMO Product Portfolio
  24. 6.4.5 MYCENAX Recent Developments
  25. 6.5 RoosterBio
  26. 6.5.1 RoosterBio Company Information
  27. 6.5.2 RoosterBio Business Overview
  28. 6.5.3 RoosterBio Exosome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 RoosterBio Exosome CDMO Product Portfolio
  30. 6.5.5 RoosterBio Recent Developments
  31. 6.6 Altaris LLC
  32. 6.6.1 Altaris LLC Company Information
  33. 6.6.2 Altaris LLC Business Overview
  34. 6.6.3 Altaris LLC Exosome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Altaris LLC Exosome CDMO Product Portfolio
  36. 6.6.5 Altaris LLC Recent Developments
  37. 6.7 Asahi Glass Co.
  38. 6.7.1 Asahi Glass Co. Company Information
  39. 6.7.2 Asahi Glass Co. Business Overview
  40. 6.7.3 Asahi Glass Co. Exosome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Asahi Glass Co. Exosome CDMO Product Portfolio
  42. 6.7.5 Asahi Glass Co. Recent Developments
  43. 6.8 Fortis Life Sciences
  44. 6.8.1 Fortis Life Sciences Company Information
  45. 6.8.2 Fortis Life Sciences Business Overview
  46. 6.8.3 Fortis Life Sciences Exosome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Fortis Life Sciences Exosome CDMO Product Portfolio
  48. 6.8.5 Fortis Life Sciences Recent Developments
  49. 6.9 Scorpius BioManufacturing
  50. 6.9.1 Scorpius BioManufacturing Company Information
  51. 6.9.2 Scorpius BioManufacturing Business Overview
  52. 6.9.3 Scorpius BioManufacturing Exosome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Scorpius BioManufacturing Exosome CDMO Product Portfolio
  54. 6.9.5 Scorpius BioManufacturing Recent Developments
  55. 6.10 Miltenyi Bioindustry
  56. 6.10.1 Miltenyi Bioindustry Company Information
  57. 6.10.2 Miltenyi Bioindustry Business Overview
  58. 6.10.3 Miltenyi Bioindustry Exosome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Miltenyi Bioindustry Exosome CDMO Product Portfolio
  60. 6.10.5 Miltenyi Bioindustry Recent Developments
  61. 6.11 Exothera
  62. 6.11.1 Exothera Company Information
  63. 6.11.2 Exothera Business Overview
  64. 6.11.3 Exothera Exosome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Exothera Exosome CDMO Product Portfolio
  66. 6.11.5 Exothera Recent Developments
  67. 6.12 EXO Biologics
  68. 6.12.1 EXO Biologics Company Information
  69. 6.12.2 EXO Biologics Business Overview
  70. 6.12.3 EXO Biologics Exosome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 EXO Biologics Exosome CDMO Product Portfolio
  72. 6.12.5 EXO Biologics Recent Developments
  73. 6.13 Porton Advanced
  74. 6.13.1 Porton Advanced Company Information
  75. 6.13.2 Porton Advanced Business Overview
  76. 6.13.3 Porton Advanced Exosome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Porton Advanced Exosome CDMO Product Portfolio
  78. 6.13.5 Porton Advanced Recent Developments
  79. 6.14 Elise Biopharma
  80. 6.14.1 Elise Biopharma Company Information
  81. 6.14.2 Elise Biopharma Business Overview
  82. 6.14.3 Elise Biopharma Exosome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Elise Biopharma Exosome CDMO Product Portfolio
  84. 6.14.5 Elise Biopharma Recent Developments
  85. 6.15 Evox Therapeutics
  86. 6.15.1 Evox Therapeutics Company Information
  87. 6.15.2 Evox Therapeutics Business Overview
  88. 6.15.3 Evox Therapeutics Exosome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Evox Therapeutics Exosome CDMO Product Portfolio
  90. 6.15.5 Evox Therapeutics Recent Developments
  91. 6.16 FUJIFILM Biotechnologies
  92. 6.16.1 FUJIFILM Biotechnologies Company Information
  93. 6.16.2 FUJIFILM Biotechnologies Business Overview
  94. 6.16.3 FUJIFILM Biotechnologies Exosome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 FUJIFILM Biotechnologies Exosome CDMO Product Portfolio
  96. 6.16.5 FUJIFILM Biotechnologies Recent Developments
7 North America
  1. 7.1 North America Exosome CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Exosome CDMO Market Size by Country (2021-2026)
  3. 7.3 North America Exosome CDMO Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Exosome CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Exosome CDMO Market Size by Country (2021-2026)
  3. 8.3 Europe Exosome CDMO Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Exosome CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Exosome CDMO Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Exosome CDMO Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Exosome CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Exosome CDMO Market Size by Country (2021-2026)
  3. 10.3 South America Exosome CDMO Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Exosome CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Exosome CDMO Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Exosome CDMO Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst